Suchergebnisse - "Leroux-Roels, Geert"

PubPharm (363)

1

Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate : a randomised, double-blind, placebo-controlled, phase 2a trial

enthalten in: The Lancet. Infectious diseases | 2023

von Leroux-Roels, I. | Willems, P. | Waerlop, G. | +9

2

Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols

enthalten in: Journal of immunological methods | 2023

von Waerlop, G. | Leroux-Roels, G. | Pagnon, A. | +15

3

Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis : a randomised, phase 1 study in healthy adults

enthalten in: The Lancet. Infectious diseases | 2023

von Bézay, N. | Hochreiter, R. | Kadlecek, V. | +8

CommentIn: Lancet Infect Dis. 2023 Oct;23(10):1105-1106. - PMID 37419127

4

Dissecting human population variation in single-cell responses to SARS-CoV-2

enthalten in: Nature | 2023

von Aquino, Y. | Bisiaux, A. | Li, Z. | +28

5

Corrigendum to "Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults : A phase 2 randomized study" [Vaccine: X 11 (2022) 100189

enthalten in: Vaccine: X | 2023

von Sáez-Llorens, X. | Lanata, C. | Aranguren, E. | +20

ErratumFor: Vaccine X. 2022 Aug;11:100189. - PMID 35791320

6

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection

enthalten in: JHEP reports : innovation in hepatology | 2023

von Burm, R. | Van Houtte, F. | Verhoye, L. | +6

7

Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine

enthalten in: Vaccines | 2023

von Leroux-Roels, I. | Bruhwyler, J. | Stergiou, L. | +5

8

Human Immunity and Susceptibility to Influenza A(H3) Viruses of Avian, Equine, and Swine Origin

enthalten in: Emerging infectious diseases | 2023

von Vandoorn, E. | Stadejek, W. | Leroux-Roels, I. | +3

9

Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant

enthalten in: Frontiers in immunology | 2023

von Waerlop, G. | Janssens, Y. | Jacobs, B. | +6

10

Environmental and genetic drivers of population differences in SARS-CoV-2 immune responses

enthalten in: bioRxiv.org | 2022

von Aquino, Y. | Bisiaux, A. | Li, Z. | +28

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[37]